Mereo BioPharma Group (NASDAQ:MREO) Lifted to “Strong-Buy” at Baird R W
Baird R W upgraded shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) to a strong-buy rating in a research note published on Thursday, Zacks.com reports. Several other research firms have also weighed in on MREO. Robert W. Baird started coverage on Mereo BioPharma Group in a report on Thursday. They set an outperform rating […]
More Stories
American Vanguard Co. (NYSE:AVD) Declares $0.03 Quarterly Dividend
American Vanguard Co. (NYSE:AVD – Get Free Report) announced a quarterly dividend on Thursday, June 6th, NASDAQ reports. Stockholders of...
The Quintessential Quintuplets Season 3: What Are the Release Dates?
The Quintessential Quintuplets, a Manga series, made its debut on August 9, 2017, and has attracted a huge viewership. With...
CarMax (NYSE:KMX) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS
CarMax (NYSE:KMX – Get Free Report) released its earnings results on Friday. The company reported $0.97 EPS for the quarter,...
Charter Hall Long WALE REIT (CLW) To Go Ex-Dividend on June 26th
Charter Hall Long WALE REIT (ASX:CLW – Get Free Report) announced a final dividend on Monday, June 17th, MarketIndexAU reports....
China Overseas Land & Investment Limited (OTCMKTS:CAOVY) Announces Dividend Increase – $0.24 Per Share
China Overseas Land & Investment Limited (OTCMKTS:CAOVY – Get Free Report) announced a dividend on Monday, June 10th, NASDAQ reports....
FactSet Research Systems (NYSE:FDS) Issues FY 2024 Earnings Guidance
FactSet Research Systems (NYSE:FDS – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided EPS...